This inventor holds 4 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Astellas Pharma Gmbh, Tottori University. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 424 
1 out of 61 
Years Active: 2019-2023
Title: Shinsuke Nakao: Innovator in Cancer Therapy
Introduction
Shinsuke Nakao, a prominent inventor based in Tokyo, Japan, has made significant strides in the field of cancer therapy through his innovative research. With a total of four patents to his name, Nakao’s work focuses on groundbreaking approaches that harness the power of immunotherapy and genetic engineering to combat cancer.
Latest Patents
Among his latest patents are methods for cancer therapy involving a combination of oncolytic vaccinia virus and immune checkpoint inhibitors. This innovative therapy utilizes genetically modified vaccinia virus, particularly oncolytic variants, administered alongside another cancer treatment to enhance therapy effectiveness. Nakao's patented formulations include a combination therapy featuring vaccinia virus that encodes crucial cytokines such as interleukin-7 (IL-7) and interleukin-12 (IL-12), along with a pharmaceutical composition designed for optimized therapeutic use. Additionally, he has developed an anti-human BDCA-2 antibody aimed at preventing and treating autoimmune diseases by modulating plasmacytoid dendritic cells through specific binding.
Career Highlights
Shinsuke Nakao has held positions at leading organizations such as Astellas Pharma GmbH and the National University Corporation Tottori University. His roles in these significant institutions have undoubtedly contributed to his deep understanding of pharmaceuticals and cancer research, further propelling his innovative contributions to the medical field.
Collaborations
Throughout his career, Nakao has collaborated with talented individuals including colleagues Tatsuya Kawase and Masayuki Ito. These partnerships have likely enriched his research endeavors, allowing for a multidisciplinary approach to complex medical challenges.
Conclusion
Shinsuke Nakao's contributions to cancer therapy exemplify the profound impact that inventors can have on medical science. With his innovative patents and collaborative efforts, he continues to pave the way for novel treatments that hold the potential to transform patient outcomes in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile